ChiCTR2100049744
Untitled Trial
A randomized, double blind and placebo controlled phase I/II clinical trial to explore the safety and immunogenicity of the COVID 19 DNA vaccine used as a boost dose to subjects previously immunized with COVID 19 inactivated vaccines
Sichuan Provincial Center for Disease Control and Prevention·Phase 1/2·Chinese Clinical Trial RegistryCompleted
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Novel Coronavirus Pneumonia (COVID 19)
Sponsor & location
- Primary sponsor
- Sichuan Provincial Center for Disease Control and Prevention
- Funder
- sponsor
- Location
- China
Timeline & enrollment
- Phase
- Phase 1/2
- Start date
- N/A
- End date
- Jan 15, 2023
ICD-10 classifications
COVID-19, virus identifiedViral pneumonia, unspecifiedOther viral pneumoniaCOVID-19, virus not identifiedPneumonia in viral diseases classified elsewhere
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100049744
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100049744 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Sichuan Provincial Center for Disease Control and Prevention and is currently Completed. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.